PMID: 8952375Nov 1, 1996Paper

The World Health Organization Short Disability Assessment Schedule (WHO DAS-S): a tool for the assessment of difficulties in selected areas of functioning of patients with mental disorders

Social Psychiatry and Psychiatric Epidemiology
A JancaN Sartorius

Abstract

The World Health Organization Short Disability Assessment Schedule (WHO DAS-S) is an instrument for clinicians' assessment and rating of difficulties in maintaining personal care, in performing occupational tasks and in functioning in relation to the family and the broader social context due to mental disorders. The WHO DAS-S was developed and underwent preliminarily testing in the context of two international field trials of the multiaxial presentation of ICD-10 for use in adult psychiatry. The instrument was found to be useful, user-friendly and reasonably reliable for use by clinicians belonging to different schools of psychiatry and psychiatric traditions. Further work on the WHO DAS-S should include development of national adaptations of the instrument, studies of concurrent validity of the instrument and modification of the instrument to accommodate changes in the next edition of the International Classification of Impairments, Disabilities and Handicaps (ICIDH).

References

Oct 1, 1989·Computers and Biomedical Research, an International Journal·C W Ahn, J E Mezzich
Jan 1, 1981·Journal of Psychiatric Research·J E MezzichG A Coffman
Apr 1, 1995·Disability and Rehabilitation·T B UstünN Sartorius
Mar 1, 1996·The Journal of Nervous and Mental Disease·A JancaN Sartorius
Dec 11, 1987·Health Policy·K S Johansen

❮ Previous
Next ❯

Citations

Feb 5, 2002·European Archives of Psychiatry and Clinical Neuroscience·M Kastrup, J E Mezzich
May 20, 2005·Social Psychiatry and Psychiatric Epidemiology·M V KaridiC N Stefanis
Mar 15, 2008·Social Psychiatry and Psychiatric Epidemiology·Susana OchoaUNKNOWN NEDES Group
May 21, 2008·Social Psychiatry and Psychiatric Epidemiology·Ulrich A ReininghausTom K J Craig
Dec 12, 2012·Social Psychiatry and Psychiatric Epidemiology·Laia Mas-ExpósitoLluís Lalucat-Jo
Oct 19, 2004·European Child & Adolescent Psychiatry·Bjørg Elisabeth Haugen Schorre, Inger Helene Vandvik
Apr 1, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I E A-ElbasitH A Giha
Jun 19, 2013·Community Mental Health Journal·Laia Mas-ExpósitoLluís Lalucat-Jo
Feb 4, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Laia Mas-ExpósitoUNKNOWN Research Group on Severe Mental Disorder
Sep 2, 2008·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Eugenia Oviedo-JoekesMartin T Schechter
Mar 10, 2004·Psychiatry Research·Carmel M LoughlandJane M Walton
Jun 22, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·J BobesM Bousoño
Oct 1, 2009·Revista de psiquiatrí́a y salud mental·Maribel AhuirPedro Gallo
Dec 11, 2002·The Australian Journal of Rural Health·Samar AounAleksandar Janca
Jul 6, 2000·The Australian and New Zealand Journal of Psychiatry·M Hambrecht, H Häfner
Jan 22, 2003·The Australian and New Zealand Journal of Psychiatry·Vaughan J CarrTerry J Lewin
Nov 14, 2013·Journal of Clinical and Experimental Neuropsychology·Leanne K WilkinsJohn King
Sep 2, 2008·Journal of Child and Adolescent Psychopharmacology·Josefina Castro-FornielesCelso Arango
Jun 17, 2008·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Gerardo FlorezJulio Bobes
Nov 27, 2009·International Journal of Epidemiology·Manoj Mohanan, Joanna Maselko
Oct 6, 2010·Health Research Policy and Systems·Karina GibertLuis Salvador-Carulla
Aug 23, 2012·Indian Journal of Public Health·K H RajeevS M Ravikumar
Aug 19, 2004·European Journal of Clinical Pharmacology·Lorenza MaglianoUNKNOWN National Mental Health Project Working Group
May 31, 2008·Social Psychiatry and Psychiatric Epidemiology·Kathleen VanheusdenJohan P Mackenbach
Jul 3, 2008·European Archives of Psychiatry and Clinical Neuroscience·Heinz HäfnerKurt Maurer
Jun 4, 2005·Der Nervenarzt·K MaurerH Häfner
Apr 9, 2014·European Archives of Psychiatry and Clinical Neuroscience·Sofía RotgerJosep Antoni Ramos-Quiroga
Sep 22, 2012·Comprehensive Psychiatry·Ana BarajasJudith Usall
Aug 3, 2012·Revista de psiquiatrí́a y salud mental·Elena EzquiagaAlfonso Rodriguez
Sep 10, 2010·Schizophrenia Research·José Manuel Rodríguez-SánchezBenedicto Crespo-Facorro
Jun 26, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·B AusínE Pérez-Santos
Mar 7, 2009·Journal of Affective Disorders·Louise K SjöholmCatharina Lavebratt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.